Literature DB >> 16352635

Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.

E Reefman1, H Kuiper, M F Jonkman, P C Limburg, C G M Kallenberg, M Bijl.   

Abstract

OBJECTIVES: Accumulation of apoptotic cells has been suggested to be involved in the pathogenesis of systemic lupus erythematosus (SLE). As sunlight exposure is one of the factors that can trigger disease activity, we hypothesized that UV light may induce increased numbers of apoptotic cells in SLE.
METHODS: Fourteen SLE patients and 16 controls were irradiated with UVB to determine their minimal erythemal dose (MED). Subsequently, skin was irradiated with 1 MED and 2 MED, respectively, and after 24 h skin biopsies were analysed immunohistologically for the number of apoptotic cells and presence of pyknotic nuclear debris.
RESULTS: MED was significantly decreased in SLE patients and the presence of decreased MED was associated with a history of butterfly rash. Decreased MED was not related to other skin-related ACR criteria or to autoantibody specificities. No differences were detected in the numbers of apoptotic keratinocytes between patients and controls or in the amount of pyknotic nuclear debris following 1 and 2 MED irradiation, respectively. Absolute UVB doses were correlated with the number of apoptotic keratinocytes; dose-responses did not differ significantly between patients and controls.
CONCLUSIONS: Increased sensitivity of SLE patients to UVB, although associated with a history of malar rash, is not related to increased induction of apoptosis or increased levels of secondary necrosis in the skin. Thus, compared with controls, UVB-induced apoptosis is not increased in SLE patients under physiological conditions.

Entities:  

Mesh:

Year:  2005        PMID: 16352635     DOI: 10.1093/rheumatology/kei249

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  Apoptotic cell death and lupus.

Authors:  Philip L Cohen
Journal:  Springer Semin Immunopathol       Date:  2006-08-29

2.  Immunogenetics of Lupus Erythematosus.

Authors:  Begüm Ünlü; Ümit Türsen; Navid Jabalameli; Fahimeh Abdollahimajd; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report.

Authors:  Pia Vihinen; Outi Paija; Atte Kivisaari; Leena Koulu; Heikki Aho
Journal:  J Med Case Rep       Date:  2011-06-27

Review 4.  Disturbances of apoptotic cell clearance in systemic lupus erythematosus.

Authors:  Wen-Hai Shao; Philip L Cohen
Journal:  Arthritis Res Ther       Date:  2011-02-28       Impact factor: 5.156

5.  Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?

Authors:  Esther Reefman; Marcelus C J M de Jong; Hilde Kuiper; Marcel F Jonkman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  Human and Murine Evidence for Mechanisms Driving Autoimmune Photosensitivity.

Authors:  Sonya J Wolf; Shannon N Estadt; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

7.  Shining light on lupus and UV.

Authors:  Melanie K Kuechle; Keith B Elkon
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 8.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Jordan C Achtman; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2015-08-10       Impact factor: 5.156

Review 9.  Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

Authors:  Jucélio Pereira Moura Filho; Raiza Luna Peixoto; Lívia Gomes Martins; Sillas Duarte de Melo; Ligiana Leite de Carvalho; Ana Karine F da Trindade C Pereira; Eutilia Andrade Medeiros Freire
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.